Skip to main content
Top
Published in: Virchows Archiv 1/2014

01-01-2014 | Original Article

Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma

Authors: R. Salzman, I. Stárek, L. Kučerová, A. Skálová, J. Hoza

Published in: Virchows Archiv | Issue 1/2014

Login to get access

Abstract

Recent research suggests that multinodular recurrent pleomorphic adenoma (PA) might result from cell migration through lymphatics. Lymphangiogenesis in malignancies is mediated by vascular endothelial growth factors C and D (VEGF-C/D). We studied the expression of VEGF-C/D in PA by immunohistochemistry as well as lymphatic vessel density (LVD). In 6 non-recurrent, 4 primary-to-recur, and 10 recurrent PAs, VEGF-C/D expression was assessed by immunohistochemistry. Staining was scored in terms of staining intensity (0 = absent to 3 = strong), and the percentage of positive tumor cells (scored as 0 (0–19 %), 1 (20–39 %), 2 (40–50 %), and 3 (60–100 %)) and a sum score were calculated. Intra- and peritumoral LVD was assessed by counting of LV after immunostaining, using the D2-40 antibody. All but one sample were VEGF-C negative. The differences in VEGF-D expression between non-recurrent, primary-to-recur, and recurrent PAs were not significant (p > 0.05). VEGF-D expression did not correlate with peritumoral LVD (p > 0.05). Our study revealed a significant difference between intra- and peritumoral LVD values when comparing individual and all sample groups (p = 0.01). The lack of VEGF-C expression and of significant differences in VEGF-D expression and peritumoral LVD between patients with non-recurrent, primary-to-recur, and recurrent PAs does not support the lymphangiogenic local spread hypothesis.
Literature
1.
go back to reference Goudot P (1989) Pleomorphic adenoma of the salivary glands. Impact of the myxoid component on the prognosis. Rev Stomatol Chir Maxillofac 90:119–122PubMed Goudot P (1989) Pleomorphic adenoma of the salivary glands. Impact of the myxoid component on the prognosis. Rev Stomatol Chir Maxillofac 90:119–122PubMed
2.
go back to reference McGregor AD, Burgyone M, Tan KC (1988) Recurrent pleomorphic salivary adenoma—the relevance of age at first presentation. Br J Plast Surg 41:177–181PubMedCrossRef McGregor AD, Burgyone M, Tan KC (1988) Recurrent pleomorphic salivary adenoma—the relevance of age at first presentation. Br J Plast Surg 41:177–181PubMedCrossRef
3.
go back to reference Zbären P, Stauffer E (2007) Pleomorphic adenoma of the parotid gland. Histopathologic analysis of the capsular characteristics of 218 cases. Head Neck 29:751–757PubMedCrossRef Zbären P, Stauffer E (2007) Pleomorphic adenoma of the parotid gland. Histopathologic analysis of the capsular characteristics of 218 cases. Head Neck 29:751–757PubMedCrossRef
4.
go back to reference Stennert E et al (2004) Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study. Laryngoscope 114:1538–1543CrossRef Stennert E et al (2004) Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study. Laryngoscope 114:1538–1543CrossRef
5.
go back to reference Brieger J (2008) Recurrence of pleomorphic adenoma of the parotid gland—predictive value of cadherin-11 and fascin. APMIS 116:1050–1057PubMedCrossRef Brieger J (2008) Recurrence of pleomorphic adenoma of the parotid gland—predictive value of cadherin-11 and fascin. APMIS 116:1050–1057PubMedCrossRef
6.
go back to reference Cao Y (2005) Opinion: emerging mechanism of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 5:735–743PubMedCrossRef Cao Y (2005) Opinion: emerging mechanism of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 5:735–743PubMedCrossRef
7.
go back to reference Hazan RB, Qiao R, Keren R, Badano I, Suyama K (2004) Cadherin switch in tumor progression. Ann N Y Acad Sci 1014:155–163PubMedCrossRef Hazan RB, Qiao R, Keren R, Badano I, Suyama K (2004) Cadherin switch in tumor progression. Ann N Y Acad Sci 1014:155–163PubMedCrossRef
8.
go back to reference Yamazaki Y, Morita T (2006) Molecular and functional diversity of vascular endothelial growth factors. Mol Divers 10(4):515–527PubMedCrossRef Yamazaki Y, Morita T (2006) Molecular and functional diversity of vascular endothelial growth factors. Mol Divers 10(4):515–527PubMedCrossRef
9.
go back to reference Matilla MMT, Ruohola JK, Karpanen T, Jackson DG, Alitalo K, Härkönen P (2002) VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 98:946–951CrossRef Matilla MMT, Ruohola JK, Karpanen T, Jackson DG, Alitalo K, Härkönen P (2002) VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 98:946–951CrossRef
10.
11.
go back to reference Pepper MS, Tille JC, Nisato R et al (2003) Lymphangiogenesis and tumor metastasis. Cell Tissue Res 314:167–177PubMedCrossRef Pepper MS, Tille JC, Nisato R et al (2003) Lymphangiogenesis and tumor metastasis. Cell Tissue Res 314:167–177PubMedCrossRef
12.
go back to reference Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2:192–198CrossRef Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2:192–198CrossRef
13.
go back to reference Stacker SA, Achen MG, Jussila L et al (2002) Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2:573–583PubMedCrossRef Stacker SA, Achen MG, Jussila L et al (2002) Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2:573–583PubMedCrossRef
14.
go back to reference Stacker SA, Caesar C, Baldwin ME et al (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186–191PubMedCrossRef Stacker SA, Caesar C, Baldwin ME et al (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186–191PubMedCrossRef
15.
go back to reference Hu W-G, Li J-W, Feng B, Beveridge M, Yue F, Lu A-G, Ma J-J, Wang M-L, Guo Y, Jin X-L, Zheng M-H (2007) Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Eur Surg Res 39(4):229–238PubMedCrossRef Hu W-G, Li J-W, Feng B, Beveridge M, Yue F, Lu A-G, Ma J-J, Wang M-L, Guo Y, Jin X-L, Zheng M-H (2007) Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Eur Surg Res 39(4):229–238PubMedCrossRef
16.
go back to reference Choi WW, Lewis MM, Lawson D, Yi-Goen Q, Birdsong GG, Cotsonins GA, Cohen C, Young AN (2005) Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 18:143–152PubMedCrossRef Choi WW, Lewis MM, Lawson D, Yi-Goen Q, Birdsong GG, Cotsonins GA, Cohen C, Young AN (2005) Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 18:143–152PubMedCrossRef
17.
go back to reference Salven P, Lymboussaki A, Heikkila P, Jääskela-Saari H, Enholm B, Aase K, Euler G, Eriksson U, Alitalo K, Joensuu H (1998) Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 153(1):103–108PubMedCrossRef Salven P, Lymboussaki A, Heikkila P, Jääskela-Saari H, Enholm B, Aase K, Euler G, Eriksson U, Alitalo K, Joensuu H (1998) Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 153(1):103–108PubMedCrossRef
18.
go back to reference Tsurusaki T, Kanda S, Sakai H, Saito Y, Alitalo K, Koji T (1999) Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 80:309–313PubMedCentralPubMedCrossRef Tsurusaki T, Kanda S, Sakai H, Saito Y, Alitalo K, Koji T (1999) Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 80:309–313PubMedCentralPubMedCrossRef
19.
go back to reference Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, Matsutani N, Yasui W, Chayama K (2001) Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer 93:662–666PubMedCrossRef Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, Matsutani N, Yasui W, Chayama K (2001) Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer 93:662–666PubMedCrossRef
20.
go back to reference O-charoenrat P, Rhys-Evans P, Eccles SA (2001) Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 92(3):556–568PubMedCrossRef O-charoenrat P, Rhys-Evans P, Eccles SA (2001) Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 92(3):556–568PubMedCrossRef
21.
go back to reference Baek SK, Jung KY, Lee SH, Woo JS, Kwon SY, Chung EJ, Kim TH, Chae YS (2009) Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density is supraglottic squamous cell carcinoma. Laryngoscope 119:1325–1330PubMedCrossRef Baek SK, Jung KY, Lee SH, Woo JS, Kwon SY, Chung EJ, Kim TH, Chae YS (2009) Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density is supraglottic squamous cell carcinoma. Laryngoscope 119:1325–1330PubMedCrossRef
22.
go back to reference Fujita G, Sato S, Kishino M, Iwai S, Nakazawa M, Toyosawa S, Yukra Y, Ogawa Y (2011) Lymphatic vessels and related factors in adenoid cystic carcinoma of the salivary gland. Mod Pathol 24(7):885–891PubMedCrossRef Fujita G, Sato S, Kishino M, Iwai S, Nakazawa M, Toyosawa S, Yukra Y, Ogawa Y (2011) Lymphatic vessels and related factors in adenoid cystic carcinoma of the salivary gland. Mod Pathol 24(7):885–891PubMedCrossRef
23.
go back to reference Mello MF, Costa AF, Freitas LL, Soares AB, Araujo VC, Tincani AJ, Martins AS, Altemani A (2011) Lymphatic vessel density and expressions of lymphangiogenic growth factors in salivary carcinomas. Neoplasma 58(4):331–336PubMedCrossRef Mello MF, Costa AF, Freitas LL, Soares AB, Araujo VC, Tincani AJ, Martins AS, Altemani A (2011) Lymphatic vessel density and expressions of lymphangiogenic growth factors in salivary carcinomas. Neoplasma 58(4):331–336PubMedCrossRef
24.
go back to reference Moriyama M, Kumagai S, Kawashiri S, Kojima K, Kakihara K, Yamamoto E (1997) Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 33(5):369–374PubMedCrossRef Moriyama M, Kumagai S, Kawashiri S, Kojima K, Kakihara K, Yamamoto E (1997) Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 33(5):369–374PubMedCrossRef
25.
go back to reference Lim JJ, Kang S, Lee MR, Pai HK, Yoon HJ, Lee JI, Hong SP, Lim CY (2003) Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 32(9):552–561PubMed Lim JJ, Kang S, Lee MR, Pai HK, Yoon HJ, Lee JI, Hong SP, Lim CY (2003) Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 32(9):552–561PubMed
26.
27.
go back to reference Soares AB, Souza A, Santos F, Altemani A, Soares A, Araujo V (2011) The increased p16 expression in recurrence of salivary gland pleomorphic adenoma. Virchows Arch 459(Suppl 1):S118 Soares AB, Souza A, Santos F, Altemani A, Soares A, Araujo V (2011) The increased p16 expression in recurrence of salivary gland pleomorphic adenoma. Virchows Arch 459(Suppl 1):S118
28.
go back to reference Soares AB, Demasi AP, Altemani A, de Araujo VC (2011) Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma. Histopathology 58:377–382PubMedCrossRef Soares AB, Demasi AP, Altemani A, de Araujo VC (2011) Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma. Histopathology 58:377–382PubMedCrossRef
29.
go back to reference Soares AB, Demasi AP, Tincani AJ, Martins AS, Altemani A, de Araújo VC (2012) The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma. J Clin Pathol 65:272–277PubMedCrossRef Soares AB, Demasi AP, Tincani AJ, Martins AS, Altemani A, de Araújo VC (2012) The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma. J Clin Pathol 65:272–277PubMedCrossRef
30.
go back to reference Khademi B, Geramizadeh B, Gandorni B, Ghanbarian S (2003) Metastasizing pleomorphic adenoma of the tongue. Iran J Med Sci 28(3):143–145 Khademi B, Geramizadeh B, Gandorni B, Ghanbarian S (2003) Metastasizing pleomorphic adenoma of the tongue. Iran J Med Sci 28(3):143–145
31.
go back to reference Steele NP, Wenig BM, Sessions RB (2007) A case of pleomorphic adenoma of the parotid gland metastasizing to a mediastinal lymph node. Am J Otolaryngol 28(2):130–133PubMedCrossRef Steele NP, Wenig BM, Sessions RB (2007) A case of pleomorphic adenoma of the parotid gland metastasizing to a mediastinal lymph node. Am J Otolaryngol 28(2):130–133PubMedCrossRef
32.
go back to reference Padera TP, Kadambi A, Di Tomaso E, Carreira CM, Brown EB et al (2002) Lymphatic metastasis in the absence of functional intratumoral lymphatics. Science 296:1883–1886PubMedCrossRef Padera TP, Kadambi A, Di Tomaso E, Carreira CM, Brown EB et al (2002) Lymphatic metastasis in the absence of functional intratumoral lymphatics. Science 296:1883–1886PubMedCrossRef
33.
34.
go back to reference Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK (2000) Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60:4324–4327PubMed Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK (2000) Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60:4324–4327PubMed
35.
go back to reference Tanigawa N et al (1981) Experimental study on lymphatic vascular changes in the development of cancer. Lymphology 14:149–154PubMed Tanigawa N et al (1981) Experimental study on lymphatic vascular changes in the development of cancer. Lymphology 14:149–154PubMed
36.
go back to reference Audet N, Beasly NJ, MacMillan C, Jackson DG, Gullane PJ et al (2005) Lymphatic vessel density, nodal metastasis, and prognosis in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 131:1065–1070PubMedCrossRef Audet N, Beasly NJ, MacMillan C, Jackson DG, Gullane PJ et al (2005) Lymphatic vessel density, nodal metastasis, and prognosis in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 131:1065–1070PubMedCrossRef
37.
go back to reference Beasly NJ, Prevo R, Banerji S, Leek RD, Moore et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62:1315–1320 Beasly NJ, Prevo R, Banerji S, Leek RD, Moore et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62:1315–1320
38.
go back to reference Dadras SS, Paul T, Bertoncini J, Brown LF, Muzikansky A, Jackson DG, Ellwanger U, Garbe C, Mihm M, Detmar M (2003) Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162(6):1951–1960PubMedCrossRef Dadras SS, Paul T, Bertoncini J, Brown LF, Muzikansky A, Jackson DG, Ellwanger U, Garbe C, Mihm M, Detmar M (2003) Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162(6):1951–1960PubMedCrossRef
39.
go back to reference Kyzas PA, Geleff S, Batistatou A et al (2005) Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 206:170–177PubMedCrossRef Kyzas PA, Geleff S, Batistatou A et al (2005) Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 206:170–177PubMedCrossRef
40.
go back to reference Schmid K, Birner P, Gravenhorst V et al (2005) Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung. Am J Surg Pathol 29:324–328PubMedCrossRef Schmid K, Birner P, Gravenhorst V et al (2005) Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung. Am J Surg Pathol 29:324–328PubMedCrossRef
41.
go back to reference Schoppmann SF, Horvath R, Birner P (2002) Lymphatic vessels and lymphangiogenesis in female cancer: mechanism, clinical impact and possible implications for anti-lymphangiogenic therapies (Review). Oncol Rep 9:455–460PubMed Schoppmann SF, Horvath R, Birner P (2002) Lymphatic vessels and lymphangiogenesis in female cancer: mechanism, clinical impact and possible implications for anti-lymphangiogenic therapies (Review). Oncol Rep 9:455–460PubMed
42.
go back to reference Williams CSM, Leek RD, Robson AM et al (2003) Absence of lymphangiogenesis and intratumoral lymph vessels in human metastatic breast cancer. J Pathol 200:195–206PubMedCrossRef Williams CSM, Leek RD, Robson AM et al (2003) Absence of lymphangiogenesis and intratumoral lymph vessels in human metastatic breast cancer. J Pathol 200:195–206PubMedCrossRef
43.
go back to reference Teymoortash A, Schrader C, Shimoda H, Kato S, Werner JA (2007) Evidence of lymphangiogenesis in Warthin's tumor of the parotid gland. Oral Oncol 43:614–618PubMedCrossRef Teymoortash A, Schrader C, Shimoda H, Kato S, Werner JA (2007) Evidence of lymphangiogenesis in Warthin's tumor of the parotid gland. Oral Oncol 43:614–618PubMedCrossRef
44.
go back to reference Soares AB, De Araujo VC, Juliano PB, Altemani A (2009) Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma. J Oral Pathol Med 38(8):623–629PubMedCrossRef Soares AB, De Araujo VC, Juliano PB, Altemani A (2009) Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma. J Oral Pathol Med 38(8):623–629PubMedCrossRef
45.
go back to reference Swelam W, Ida-Yonemochi H, Maruyama S, Ohshiro K, Cheng J, Saku T (2005) Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma. Virchows Arch 446(6):653–662PubMedCrossRef Swelam W, Ida-Yonemochi H, Maruyama S, Ohshiro K, Cheng J, Saku T (2005) Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma. Virchows Arch 446(6):653–662PubMedCrossRef
46.
go back to reference Soares AB, Juliano PB, Araújo VC, Altemani A (2007) Lymphatic vascular density and lymphangiogenesis during tumor progression of carcinoma ex pleomorphic adenoma. J Clin Pathol 60(9):995–1000PubMedCrossRef Soares AB, Juliano PB, Araújo VC, Altemani A (2007) Lymphatic vascular density and lymphangiogenesis during tumor progression of carcinoma ex pleomorphic adenoma. J Clin Pathol 60(9):995–1000PubMedCrossRef
47.
go back to reference Currie MJ, Hanrahan V, Gunningham SP, Morrin HR, Frampton C, Han C, Robinson BA, Fox SB (2004) Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1 alpha) and the HIF-1 alfa target gene DEC1, but not lymph node metastasis in primary human breast carcinoma. J Clin Pathol 57(8):829–834PubMedCrossRef Currie MJ, Hanrahan V, Gunningham SP, Morrin HR, Frampton C, Han C, Robinson BA, Fox SB (2004) Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1 alpha) and the HIF-1 alfa target gene DEC1, but not lymph node metastasis in primary human breast carcinoma. J Clin Pathol 57(8):829–834PubMedCrossRef
48.
go back to reference Tzao C, Lee SC, Tung HJ, Hsu HS, Hsu WH, Sun GH, Yu CP, Jin JS, Cheng YL (2008) Expression of hypoxia induced factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma. Dis Markers 25(3):141–148PubMedCrossRef Tzao C, Lee SC, Tung HJ, Hsu HS, Hsu WH, Sun GH, Yu CP, Jin JS, Cheng YL (2008) Expression of hypoxia induced factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma. Dis Markers 25(3):141–148PubMedCrossRef
49.
go back to reference Harris NC, Paavonen K, Davydova N, Roufail S, Sato T, Zhang YF, Karnezis T, Stacker SA, Achen MG (2011) Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer. FASEB J 25(8):2615–2625PubMedCrossRef Harris NC, Paavonen K, Davydova N, Roufail S, Sato T, Zhang YF, Karnezis T, Stacker SA, Achen MG (2011) Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer. FASEB J 25(8):2615–2625PubMedCrossRef
Metadata
Title
Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma
Authors
R. Salzman
I. Stárek
L. Kučerová
A. Skálová
J. Hoza
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 1/2014
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-013-1502-5

Other articles of this Issue 1/2014

Virchows Archiv 1/2014 Go to the issue